ArticleCancers2020

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting.

Marcus Skribek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.